Safety Study of TAK-700 in Subjects With Prostate Cancer.

This study has been completed.
Information provided by (Responsible Party):
Millennium Pharmaceuticals, Inc. Identifier:
First received: December 4, 2007
Last updated: July 1, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)